Estonia National SARS-CoV-2 Sequencing cohort

Study profile

Description

The Estonia National SARS-CoV-2 Sequencing cohort study (KoroGenoEST Study) was to sequence and analyse the complete genomes of SARS-CoV-2 in Estonia. The study carried out the determination of SARS-CoV-2 variants, described the changes in the distribution of SARS-CoV-2 Pango lineages and performed a molecular epidemiological analysis to support the Estonian Health Board in monitoring and managing the outbreaks. Data of the study have been used to conduct in depth analyses of SARS-CoV-2 epidemic in Estonia during 2020 and 2023.

Countries involved: Estonia

Sample size: 2,630 children and 23,031 adults

Related publications:

  • Soeorg H, Päll T, Abroi A, et al. The effect of policy measures, school holidays and travel on the incidence of SARS-CoV-2 infection in children and adults in Estonia from 2021 to 2022PLoS One. 2025;20(7):e0327719. Published 2025 Jul 3. doi:10.1371/journal.pone.0327719
  • Soeorg H, Abroi A, Päll T, et al. Dynamics of SARS-CoV-2 lineages in children and adults in 2021 and 2022PLoS One. 2024;19(12):e0316213. Published 2024 Dec 20. doi:10.1371/journal.pone.0316213

Metadata collected

Click to view
 Data collected?
Demographics 
Date of birth (full or MM/YY)
Age at contact
Sex / gender
Country of birth 
Ethnic group / race / population sector
Income level 
Employment / occupation 
Other socio-economic status proxy 
Education level 
Civil status (‘marital’) 
Locality (of health care provision)
Locality (of residence)
Household size 
Household composition 
  
Hospitalisation 
Admission / discharge dates or duration
Episode dates
Episode type (e.g., general; birth) 
Diagnosis (e.g., codes)
Procedures (e.g., codes)
Procedures dates
Dispensed medications?
ICU admission
Admission type (planned/emergency) 
Hospitalisation for COVID-19
  
Primary care, outpatient care 
Date of visit / contact?
Diagnosis codes 
Dispensed medications codes 
Dispensed medications date 
Primary care utilisation summary 
  
Health status and exposures 
Height 
Weight 
Date of anthropometrics 
Chronic / co-morbid conditions~ 
Medications for chronic conditions 
Smoker in household 
Current smoker 
~ can include obesity 
  
Vaccines 
COVID-19 vaccine (timing, doses)
Type of COVID-19 vaccine
Other vaccinations / vaccination history 
  
COVID-19 symptoms & contacts 
COVID-19 episodes 
COVID-19 symptoms (type, severity, duration)
Influenza-like symptoms (type, timing, duration) 
COVID-19 health-seeking behaviour 
COVID-19 contacts in household 
Medications during C-19 episode 
  
Pregnancy & birth 
Date of delivery
Length of gestation
Birthweight
Maternal age at delivery
Pregnancy complications
Smoking pre-pregnancy 
Vaccines in pregnancy (non-COVID-19)
Parity / nulliparity
Pre-pregnancy body mass index 
Pregnancy outcome (e.g. miscarriage)
Mode of delivery 
Sex of baby
Congenital anomalies
Other newborn complications
Placental weight 
Antenatal care usage 
Currently pregnant 
  
Death 
Date of / age at death
Cause of death
  
COVID-19 laboratory tests 
Sample type tested 
Sample / specimen collection date
SARS-CoV-2 PCR test date
SARS-CoV-2 PCR pos / neg result
SARS-CoV-2 PCR Ct Value
SARS-CoV-2 LFT test date 
SARS-CoV-2 LFT test result 
Serology test date 
Serology test results 
SARS- COV-2 genomic test results 
SARS- COV-2 variant/ lineage
Other lab tests 
  
COVID-19 sample collection / storage 
Sample type collected 
Sample collection date 
Sample collection time 
Sample processing 
Sample quality 
Consent to use research sample 
Consent to share research sample